These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 17552509
1. Discovery of potent and muscle selective androgen receptor modulators through scaffold modifications. Li JJ, Sutton JC, Nirschl A, Zou Y, Wang H, Sun C, Pi Z, Johnson R, Krystek SR, Seethala R, Golla R, Sleph PG, Beehler BC, Grover GJ, Fura A, Vyas VP, Li CY, Gougoutas JZ, Galella MA, Zahler R, Ostrowski J, Hamann LG. J Med Chem; 2007 Jun 28; 50(13):3015-25. PubMed ID: 17552509 [Abstract] [Full Text] [Related]
3. Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-ones. Higuchi RI, Arienti KL, López FJ, Mani NS, Mais DE, Caferro TR, Long YO, Jones TK, Edwards JP, Zhi L, Schrader WT, Negro-Vilar A, Marschke KB. J Med Chem; 2007 May 17; 50(10):2486-96. PubMed ID: 17439112 [Abstract] [Full Text] [Related]
4. Substituted 6-(1-pyrrolidine)quinolin-2(1H)-ones as novel selective androgen receptor modulators. Martinborough E, Shen Y, Oeveren Av, Long YO, Lau TL, Marschke KB, Chang WY, López FJ, Vajda EG, Rix PJ, Viveros OH, Negro-Vilar A, Zhi L. J Med Chem; 2007 Oct 18; 50(21):5049-52. PubMed ID: 17887661 [Abstract] [Full Text] [Related]
5. Selective androgen receptor modulators based on a series of 7H-[1,4]oxazino[3,2-g]quinolin-7-ones with improved in vivo activity. Long YO, Higuchi RI, Caferro TR, Lau TL, Wu M, Cummings ML, Martinborough EA, Marschke KB, Chang WY, López FJ, Karanewsky DS, Zhi L. Bioorg Med Chem Lett; 2008 May 01; 18(9):2967-71. PubMed ID: 18400499 [Abstract] [Full Text] [Related]
6. Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in rats. Ostrowski J, Kuhns JE, Lupisella JA, Manfredi MC, Beehler BC, Krystek SR, Bi Y, Sun C, Seethala R, Golla R, Sleph PG, Fura A, An Y, Kish KF, Sack JS, Mookhtiar KA, Grover GJ, Hamann LG. Endocrinology; 2007 Jan 01; 148(1):4-12. PubMed ID: 17008401 [Abstract] [Full Text] [Related]
7. Discovery of diarylhydantoins as new selective androgen receptor modulators. Nique F, Hebbe S, Peixoto C, Annoot D, Lefrançois JM, Duval E, Michoux L, Triballeau N, Lemoullec JM, Mollat P, Thauvin M, Prangé T, Minet D, Clément-Lacroix P, Robin-Jagerschmidt C, Fleury D, Guédin D, Deprez P. J Med Chem; 2012 Oct 11; 55(19):8225-35. PubMed ID: 22897611 [Abstract] [Full Text] [Related]
9. 1-(2-Hydroxy-2-methyl-3-phenoxypropanoyl)indoline-4-carbonitrile derivatives as potent and tissue selective androgen receptor modulators. Piatnitski Chekler EL, Unwalla R, Khan TA, Tangirala RS, Johnson M, St Andre M, Anderson JT, Kenney T, Chiparri S, McNally C, Kilbourne E, Thompson C, Nagpal S, Weber G, Schelling S, Owens J, Morris CA, Powell D, Verhoest PR, Gilbert AM. J Med Chem; 2014 Mar 27; 57(6):2462-71. PubMed ID: 24527807 [Abstract] [Full Text] [Related]
12. 17beta-hydroxy-5alpha-androst-1-en-3-one (1-testosterone) is a potent androgen with anabolic properties. Friedel A, Geyer H, Kamber M, Laudenbach-Leschowsky U, Schänzer W, Thevis M, Vollmer G, Zierau O, Diel P. Toxicol Lett; 2006 Aug 20; 165(2):149-55. PubMed ID: 16621347 [Abstract] [Full Text] [Related]
13. Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part I. Aikawa K, Miyawaki T, Hitaka T, Imai YN, Hara T, Miyazaki J, Yamaoka M, Kusaka M, Kanzaki N, Tasaka A, Shiraishi M, Yamamoto S. Bioorg Med Chem; 2015 May 15; 23(10):2568-78. PubMed ID: 25862209 [Abstract] [Full Text] [Related]
14. Tissue selectivity and potential clinical applications of trenbolone (17beta-hydroxyestra-4,9,11-trien-3-one): A potent anabolic steroid with reduced androgenic and estrogenic activity. Yarrow JF, McCoy SC, Borst SE. Steroids; 2010 Jun 15; 75(6):377-89. PubMed ID: 20138077 [Abstract] [Full Text] [Related]
15. Discovery of potent & selective inhibitors of activated thrombin-activatable fibrinolysis inhibitor for the treatment of thrombosis. Bunnage ME, Blagg J, Steele J, Owen DR, Allerton C, McElroy AB, Miller D, Ringer T, Butcher K, Beaumont K, Evans K, Gray AJ, Holland SJ, Feeder N, Moore RS, Brown DG. J Med Chem; 2007 Nov 29; 50(24):6095-103. PubMed ID: 17990866 [Abstract] [Full Text] [Related]
17. Synthesis of potent and tissue-selective androgen receptor modulators (SARMs): 2-(2,2,2)-Trifluoroethyl-benzimidazole scaffold. Ng RA, Lanter JC, Alford VC, Allan GF, Sbriscia T, Lundeen SG, Sui Z. Bioorg Med Chem Lett; 2007 Mar 15; 17(6):1784-7. PubMed ID: 17197181 [Abstract] [Full Text] [Related]
18. Discovery of 6-N,N-bis(2,2,2-trifluoroethyl)amino- 4-trifluoromethylquinolin-2(1H)-one as a novel selective androgen receptor modulator. van Oeveren A, Motamedi M, Mani NS, Marschke KB, López FJ, Schrader WT, Negro-Vilar A, Zhi L. J Med Chem; 2006 Oct 19; 49(21):6143-6. PubMed ID: 17034117 [Abstract] [Full Text] [Related]
19. Synthesis, structure-activity relationships, and characterization of novel nonsteroidal and selective androgen receptor modulators. Schlienger N, Lund BW, Pawlas J, Badalassi F, Bertozzi F, Lewinsky R, Fejzic A, Thygesen MB, Tabatabaei A, Bradley SR, Gardell LR, Piu F, Olsson R. J Med Chem; 2009 Nov 26; 52(22):7186-91. PubMed ID: 19856921 [Abstract] [Full Text] [Related]